Writing Publishing Papers ACOG
-
Upload
sindhu-davuluri -
Category
Documents
-
view
225 -
download
0
Transcript of Writing Publishing Papers ACOG
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 1/36
Publication SuccessPublication Success
Why Publish?Why Publish? Fellows who do not publish during fellowship will oftenFellows who do not publish during fellowship will often
never take and pass their Boardsnever take and pass their Boards Individuals do the vast majority of completing researchIndividuals do the vast majority of completing research
and writing papers in the first seven years out of and writing papers in the first seven years out of
training.training. Publication success is the single biggest indicator of Publication success is the single biggest indicator of
academic successacademic success PromotionsPromotions
Promotions and Tenure committes place little emphasis on teachingPromotions and Tenure committes place little emphasis on teachingand patient careand patient care
Division Directors and Department ChairsDivision Directors and Department Chairs Invitations to participate in committees and boards of nationalInvitations to participate in committees and boards of national
societiessocieties Invitations to speak at national and international meetingsInvitations to speak at national and international meetings
Publishing often keeps those writing on the cutting edgePublishing often keeps those writing on the cutting edge
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 2/36
The number of unpublished studiesThe number of unpublished studies
is astounding.is astounding. Barriers to publicationBarriers to publication
Lack of mentorshipLack of mentorship
Writers inertia/blockWriters inertia/block ProcrastinationProcrastination
Competing prioritiesCompeting priorities
PersonalPersonal
ProfessionalProfessional
Rejection of first submissionRejection of first submission
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 3/36
SolutionsSolutions
Barriers to publicationBarriers to publication Lack of mentorshipLack of mentorship
Choose your mentors wiselyChoose your mentors wisely Experience, priority, nurturing, pushyExperience, priority, nurturing, pushy
Writers inertia/blockWriters inertia/block Learn good methods for writing papersLearn good methods for writing papers
ProcrastinationProcrastination Write your paper before you present it Write your paper before you present it Make it a team project Make it a team project
Competing prioritiesCompeting priorities Schedule specific times on your calendar to writeSchedule specific times on your calendar to write
Rejection of first submissionRejection of first submission Grow upGrow up rejection is part of liferejection is part of life Move onMove on get advice on the best place for the next submissionget advice on the best place for the next submission ListenListen take the advice of the reviewers before resubmissiontake the advice of the reviewers before resubmission
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 4/36
IRB/Guidelines for ConsentingIRB/Guidelines for Consenting
Subjects for R
esearchSubjects for R
esearch A uthors must follow the ethical standards for human A uthors must follow the ethical standards for human
experimentation established in the Declaration of experimentation established in the Declaration of Helsinki (World Medical A ssociation Declaration of Helsinki (World Medical A ssociation Declaration of Helsinki: recommendations guiding physicians inHelsinki: recommendations guiding physicians in
biomedical research involving human subjects. J A M A biomedical research involving human subjects. J A M A 1997;277:9251997;277:925--6).6).
A ll journals now require that you affirm IRB approval in A ll journals now require that you affirm IRB approval inyour paper and in your cover letteryour paper and in your cover letter Will often require the IRB case numberWill often require the IRB case number
Includes retrospective, chart review and data base studiesIncludes retrospective, chart review and data base studies
Most now also require patient consent for case reports.Most now also require patient consent for case reports.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 5/36
Case ReportsCase Reports
Dont waste your time!Dont waste your time! VERY low acceptance rates VERY low acceptance rates
If you do, they must beIf you do, they must be Highly unique, ANDHighly unique, AND Have implications forHave implications for
Patient management and/orPatient management and/or
Important future researchImportant future research ExampleExample
Irwin Merkatz, low A FP in Down syndromeIrwin Merkatz, low A FP in Down syndrome
A lternatively consider using the case for retrospective A lternatively consider using the case for retrospectivereviews or seeds for future studies.reviews or seeds for future studies.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 6/36
Clinicaltrials.govClinicaltrials.gov
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States andClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and
around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations,around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations,
and phone numbers for more details. This information should be used in conjunction with advice from health careand phone numbers for more details. This information should be used in conjunction with advice from health care
professionals.professionals.
Find trials for a specific medical condition or other criteria in the ClinicalTrials.gov registry. ClinicalTrials.govFind trials for a specific medical condition or other criteria in the ClinicalTrials.gov registry. ClinicalTrials.gov
currently has 79,903 trials with locations in 170 countries.currently has 79,903 trials with locations in 170 countries. Get instructions for clinical trialGet instructions for clinical trial
investigators/sponsors about how to register trials in ClinicalTrials.gov. Learn about mandatory registration andinvestigators/sponsors about how to register trials in ClinicalTrials.gov. Learn about mandatory registration and
results reporting requirements and US Public Law 110results reporting requirements and US Public Law 110--85 (FD AAA ).85 (FD AAA ). Learn about clinical trials and how to useLearn about clinical trials and how to use
ClinicalTrials.gov, or access other consumer health information from the US National Institutes of Health.ClinicalTrials.gov, or access other consumer health information from the US National Institutes of Health.
Resources:Resources:
Understanding Clinical TrialsUnderstanding Clinical Trials
What's NewWhat's New
GlossaryGlossary
Study Topics:Study Topics:
List studies by ConditionList studies by Condition
List studies by Drug InterventionList studies by Drug Intervention
List studies by SponsorList studies by Sponsor
List studies by LocationList studies by Location
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 7/36
Rules for AuthorshipRules for Authorship
Each author must qualify by having participated actively andEach author must qualify by having participated actively andsufficiently in the study reported. The inclusion of each author in thesufficiently in the study reported. The inclusion of each author in theauthorship list of a report must be based only on 1)authorship list of a report must be based only on 1) substantialsubstantialcontributionscontributions to (a) the concept and design, or analysis andto (a) the concept and design, or analysis and
interpretation of data and (b) the author's having drafted theinterpretation of data and (b) the author's having drafted themanuscript or revised it critically for important intellectual content;manuscript or revised it critically for important intellectual content;and 2) final approval by each author of the version of theand 2) final approval by each author of the version of themanuscript being submitted. A ll conditions (1a, 1b, and 2) must bemanuscript being submitted. A ll conditions (1a, 1b, and 2) must bemet. Others contributing to the work, including participants inmet. Others contributing to the work, including participants incollaborative trials, should be recognized separately in thecollaborative trials, should be recognized separately in the A cknowledgment(s) section. In the cover letter that accompanies A cknowledgment(s) section. In the cover letter that accompanies
the submitted manuscript, it must be confirmed that all bylinedthe submitted manuscript, it must be confirmed that all bylinedauthors fulfill all conditions. A ccordingly, authors are encouraged toauthors fulfill all conditions. A ccordingly, authors are encouraged tolimit the number of authors listed.limit the number of authors listed.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 8/36
Order of authorsOrder of authors
Principle InvestigatorPrinciple Investigator
Idea personIdea person
Last is senior authorLast is senior author
If idea person is senior author ask him/her which is preferredIf idea person is senior author ask him/her which is preferred
Dont include research nurses, statisticians, ghost writers unless they fulfilled allDont include research nurses, statisticians, ghost writers unless they fulfilled all
criteria for authorship, include them as acknowledgementscriteria for authorship, include them as acknowledgements
Authorship Authorship
Each author must qualify by having participated actively and sufficiently in the studyEach author must qualify by having participated actively and sufficiently in the study
reported. The inclusion of each author in the authorship list of a report must be based onlyreported. The inclusion of each author in the authorship list of a report must be based only
on 1) substantial contributions to (a) the concept and design, or analysis and interpretationon 1) substantial contributions to (a) the concept and design, or analysis and interpretationof data and (b) the author's having drafted the manuscript or revised it critically forof data and (b) the author's having drafted the manuscript or revised it critically for
important intellectual content; and 2) final approval by each author of the version of theimportant intellectual content; and 2) final approval by each author of the version of the
manuscript being submitted. A ll conditions (1a, 1b, and 2) must be met. Others contributingmanuscript being submitted. A ll conditions (1a, 1b, and 2) must be met. Others contributing
to the work, including participants in collaborative trials, should be recognized separately into the work, including participants in collaborative trials, should be recognized separately in
the A cknowledgment(s) section. In the cover letter that accompanies the submittedthe A cknowledgment(s) section. In the cover letter that accompanies the submitted
manuscript, it must be confirmed that all bylined authors fulfill all conditions.manuscript, it must be confirmed that all bylined authors fulfill all conditions.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 9/36
Abstract Submission Abstract Submission
Why:Why:
Get significant input into strengths, flaws and issueGet significant input into strengths, flaws and issuebefore submitting the paperbefore submitting the paper
ExposureExposure Often more people know about your study than from theOften more people know about your study than from the
publicationpublication
A lways for junior authors, more people know who the author A lways for junior authors, more people know who the authorwas than with the publicationwas than with the publication
FunFun
You get priority in going to the meeting You get priority in going to the meeting
You learn a lot more presenting than publishing You learn a lot more presenting than publishing
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 10/36
Writing an abstractWriting an abstract
Sell the study in the introductionSell the study in the introduction Unlike papers, dont assume the reviewer is an expert inUnlike papers, dont assume the reviewer is an expert in
the fieldthe field explain the problem clearlyexplain the problem clearly why is the studywhy is the studyso important so important
Dont include name of the institution in the abstract Dont include name of the institution in the abstract A dhere to the word limit and font size A dhere to the word limit and font size State your primary hypothesis clearlyState your primary hypothesis clearly Dont tell them the end points you chose in yourDont tell them the end points you chose in your
methods section, your results will tell themmethods section, your results will tell them Dont tell them what statistical methods you used.Dont tell them what statistical methods you used. Give them actual dataGive them actual data Overstate your conclusions a little more than you wouldOverstate your conclusions a little more than you would
in a paper.in a paper.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 11/36
Impact of a rescue course of antenatal corticosteroids ( ACS): A multi-center,randomized, controlled trial.
Objective:Previous studies using scheduled repetitive courses of A CS have demonstrated limited benefit andconcern over potential risk. We present the first study evaluating the impact of a single rescue courseof A CS on neonatal outcome
Materials and methods: A multi-center, randomized, double blind, placebo controlled trial was performed. Eligible singletons ortwins were < 33 weeks (wks), had completed a single course of betamethasone before 30 wks and at least 14 days prior, and were judged to have a recurring threat of preterm delivery in the comingweek. Patients were randomized to receive a single rescue course of A CS or placebo. Exclusion
criteria included: PROM, advanced dilation (> 5 cm), chorioamnionitis, and other steroid use. Theprimary outcome was composite neonatal morbidity at < 34 wks.
Results:437 patients were randomized (223 study group, 214 placebo). 55% of patients in each groupdelivered at < 34 wks. The groups were similar in gestational age (G A ) at randomization (29.4 wks)and at delivery (33.0 wks), delivery route, delivery indications, A PG A R scores, cord pH, and proportionof twins. There was a significant reduction in composite neonatal morbidity < 34 wks in the rescuesteroid group vs. placebo (42.5% vs. 63.3%, (RR 0.67, 0.54.-0.83, p=0.0002) as well as significantly
decreased RDS, ventilator support, and surfactant use. Perinatal mortality and other morbidities weresimilar in each group. Including all neonates (regardless of G A at delivery) in the analysis stilldemonstrated a significant reduction in composite morbidity in the rescue course group (30.3 vs.41.7 (RR 0.73, 0.58-0.91, P=.0055) and improvement in other respiratory morbidities, but no otherdifferences in outcome including head size and birth weight.
Conclusions: A dministration of a single rescue course of A CS before 33 wks improves neonataloutcome without apparent increased risk.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 12/36
Writing your paper Writing your paper
Write the abstract for presentation first Write the abstract for presentation first The original protocol should essentially write your Materials and MethodsThe original protocol should essentially write your Materials and Methods
Dont overstate what you are going to analyze in the paperDont overstate what you are going to analyze in the paper your results will define thisyour results will define this Be sure to state the hypothesis(ses) here.Be sure to state the hypothesis(ses) here.
Do the tables and figures next.Do the tables and figures next. You can then decide what to keep in tabular/figure form and what to put in the wording or You can then decide what to keep in tabular/figure form and what to put in the wording or
the results sectionthe results section Demographics first Demographics first
Location of study in the M and M sectionLocation of study in the M and M section
Number of patients and duration of study are in the results sectionNumber of patients and duration of study are in the results section
Primary hypothesis data/results next Primary hypothesis data/results next Next can be secondary or in temporal orderNext can be secondary or in temporal order
Write the introduction next Write the introduction next keep it brief keep it brief State what the issue isState what the issue is What is knownWhat is known
Why you decided to do the studyWhy you decided to do the study What you studiedWhat you studied
DiscussionDiscussion See instructions for structured discussionsSee instructions for structured discussions
A bstract last A bstract last
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 13/36
IntroductionIntroduction
Basic knowledge of subject Basic knowledge of subject Induction of labor is an increasingly common practice in the U.S.Induction of labor is an increasingly common practice in the U.S.
Remaining questionRemaining question One question in performing induction is the best method of determining who will succeedOne question in performing induction is the best method of determining who will succeed
Why is it a questionWhy is it a question Failure of induction among certain patients leads to higher cFailure of induction among certain patients leads to higher c--section ratessection rates
What is currently knownWhat is currently known Currently the best way of determining success is the Bishop scoreCurrently the best way of determining success is the Bishop score
What alternative existsWhat alternative exists Recently some data suggest that Ffn be an indicator of the readiness of the uterus for theRecently some data suggest that Ffn be an indicator of the readiness of the uterus for the
onset of labor and as such may be a possible indicator of who will have a successfulonset of labor and as such may be a possible indicator of who will have a successfulinduction of laborinduction of labor
Why should this be studied/Who says this should be studiedWhy should this be studied/Who says this should be studied A COG in its practice bulletin has noted that better markers of successful induction are A COG in its practice bulletin has noted that better markers of successful induction are
neededneeded Or, since this is so commone and the Bishop score only imprecisely measures success of Or, since this is so commone and the Bishop score only imprecisely measures success of
better markers are neededbetter markers are needed
What you decided to doWhat you decided to do
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 14/36
Materials and MethodsMaterials and Methods
Your protocol should basically write this section Your protocol should basically write this section General outlineGeneral outline
Type of studyType of study we performed a RCT of chicken soup vs. penicillin for thewe performed a RCT of chicken soup vs. penicillin for thecommon coldcommon cold
Primary hypothesisPrimary hypothesis chicken soup is at least as good as penicillinchicken soup is at least as good as penicillin IRB approvalIRB approval was obtained from WIRB for all siteswas obtained from WIRB for all sites Eligible subjectsEligible subjects ExclusionsExclusions RandomizationRandomization End pointsEnd points Data safety monitoring committeeData safety monitoring committee
A dverse events A dverse events Interim analysesInterim analyses
StatisticsStatistics Sample sizeSample size
Based on what premisesBased on what premises
Type of statisticsType of statistics Dont say what you studied unless it is not included in the results section or unless youDont say what you studied unless it is not included in the results section or unless you
need to define the end pointsneed to define the end points e.g. composite morbidity.e.g. composite morbidity. Software used for statisticsSoftware used for statistics
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 15/36
ResultsResults
Duration, datesDuration, dates
Location(s)Location(s)
Describe populationDescribe population high risk for ?, private practice,high risk for ?, private practice,middle west, etcmiddle west, etc
How many studied, whyHow many studied, why Flow sheet if RCTFlow sheet if RCT
How many in each groupHow many in each group
DemographicsDemographics
Primary end point outcomePrimary end point outcome Secondary end point(s) outcomeSecondary end point(s) outcome
Temporal orderTemporal order
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 16/36
Guidelines for Specific Types of ReportsGuidelines for Specific Types of Reports
Trial and research guidelinesTrial and research guidelinesThe following guidelines must be adhered to when formulating the study. Upon submitting the manuscript,The following guidelines must be adhered to when formulating the study. Upon submitting the manuscript,authors are to indicate on the Submission Checklist the type of trial/research used.authors are to indicate on the Submission Checklist the type of trial/research used.
Randomized controlled trial.Randomized controlled trial. A uthors are to consult the revised A uthors are to consult the revised CONSORT statement CONSORT statement (Moher D, Schulz KF,(Moher D, Schulz KF, A ltman D, for the CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality A ltman D, for the CONSORT Group. The CONSORT Statement: revised recommendations for improving the qualityof reports of parallelof reports of parallel--group randomized trials. J A M A 2001;285:1987group randomized trials. J A M A 2001;285:1987--91). A flowchart as a figure must be91). A flowchart as a figure must be
submitted in the manuscript.submitted in the manuscript.
MetaMeta--analysis or systematic review of randomized controlled trials.analysis or systematic review of randomized controlled trials. A uthors are to consult the A uthors are to consult theQUOROM statement QUOROM statement (Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM Group.(Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM Group.Improving the quality of reports of metaImproving the quality of reports of meta--analyses of randomized controlled trials: the QUOROM statement.analyses of randomized controlled trials: the QUOROM statement.Quality of Reporting of MetaQuality of Reporting of Meta--analyses. Lancet 1999;354:1896analyses. Lancet 1999;354:1896--1900).1900).
MetaMeta--analysis or systematic review of observational studies.analysis or systematic review of observational studies. A uthors are to consult the A uthors are to consult the MOOSEMOOSEguidelinesguidelines (Stroup DF, Berlin J A , Morton SC, et al, for the Meta(Stroup DF, Berlin J A , Morton SC, et al, for the Meta--analysis of Observational Studies in Epidemiologyanalysis of Observational Studies in Epidemiology[MOOSE] group. Meta[MOOSE] group. Meta--analysis of observational studies in epidemiology: a proposal for reporting. J A M A analysis of observational studies in epidemiology: a proposal for reporting. J A M A 2000;283:20082000;283:2008--12).12).
Diagnostic tests.Diagnostic tests. A uthors are to consult the A uthors are to consult the ST A RD InitiativeST A RD Initiative (Bossuyt PM, Reitsma JB, Bruns DE, et al., for(Bossuyt PM, Reitsma JB, Bruns DE, et al., forthe ST A RD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the ST A RDthe ST A RD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the ST A RD
Health economics.Health economics. In addition to the general instructions for authors and other guidelines applicable to theirIn addition to the general instructions for authors and other guidelines applicable to theirstudy (eg, CONSORT guidelines for a randomized, controlled trial), authors of health economics manuscriptsstudy (eg, CONSORT guidelines for a randomized, controlled trial), authors of health economics manuscriptsshould consider the following issues specific to such studies and address them in the manuscript and/orshould consider the following issues specific to such studies and address them in the manuscript and/orsubmission letter. A submission letter. A health economics checklist health economics checklist is to be included with the general manuscript checklist at the timeis to be included with the general manuscript checklist at the time
of submission.of submission.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 17/36
Flow SheetsFlow Sheets
In preparing a study, dont forget to keep trackIn preparing a study, dont forget to keep trackof all patients approached and eligibleof all patients approached and eligible
EligibleEligible
A pproached A pproached
DeclinedDeclined
ConsentedConsented
WithdrawnWithdrawn reasonsreasons
Lost to follow upLost to follow up reasonsreasons IncludedIncluded
A nalyzed A nalyzed
Not analyzed.Not analyzed.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 18/36
Excluded:
- Incomplete Data (3)
- Withdrawn (5)
- Did not meet criteria (3)
yMaternal age < 18 yr
(1)yDiabetic (1)
yPreeclamptic (1)
289 Subjects
Analyzed
Normal Saline
n = 97
300 Subjects
Randomized
5% Dextrose in
Normal Salinen = 94
10% Dextrose in
Normal Salinen = 98
Neonatal Data
n = 85
Neonatal Data
n = 82
Neonatal Data
n = 81
RCT of Dextrose and its effect on labor RCT of Dextrose and its effect on labor
Shrivistava et alShrivistava et al
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 19/36
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 20/36
Structured DiscussionStructured Discussion
Statement of principal findings
Strengths and weaknesses of the study
Strengths and weaknesses in relation to other
studies, discussing particularly any differences in
results
Meaning of the study: possible mechanisms and
implications for clinicians or policymakers
Unanswered questions and future research
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 21/36
Frequent FlawsFrequent Flaws
Inappropriate conclusionsInappropriate conclusions
Lack of power analysis or sufficient sample sizeLack of power analysis or sufficient sample size
Discontinued early without appropriate reasonsDiscontinued early without appropriate reasons
Improper use of statisticsImproper use of statistics Overstating the conclusions from secondaryOverstating the conclusions from secondary
analysesanalyses
Retrospective manipulation of hypothesis toRetrospective manipulation of hypothesis tomatch study resultsmatch study results
Poor English in papers from nonPoor English in papers from non--EnglishEnglishspeaking authorsspeaking authors
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 22/36
Choosing a JournalChoosing a Journal
A udience A udience
Subspecialty, generalSubspecialty, general
PrestigePrestige Studys Impact Studys Impact
Likelihood of acceptanceLikelihood of acceptance
Connections??Connections?? Impact Factor, Citation IndexImpact Factor, Citation Index
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 23/36
Suggested ReviewersSuggested Reviewers
Upon submitting a manuscript, authors are required to provide the name,Upon submitting a manuscript, authors are required to provide the name,address, and eaddress, and e--mail address of at least 3 potential reviewers for editorialmail address of at least 3 potential reviewers for editorialconsideration. Suggested reviewers may include anyone knowledgeable inconsideration. Suggested reviewers may include anyone knowledgeable inthe area of study presented. A uthors should not knowingly recommend as athe area of study presented. A uthors should not knowingly recommend as apotential reviewer a person with a potential conflict of interest, eitherpotential reviewer a person with a potential conflict of interest, eitherfinancial or personal (positive or negative bias), such as a mentor or closefinancial or personal (positive or negative bias), such as a mentor or close
associate. A
dditionally, the authors should not recommend any individualsassociate. A
dditionally, the authors should not recommend any individualslocated at the same institution as any of the authors.located at the same institution as any of the authors.
Other factsOther facts
Editors variably use suggested reviewersEditors variably use suggested reviewers
A uthors may ask certain reviewer(s) not be used A uthors may ask certain reviewer(s) not be used
A
verage acceptance of a reviewer invitation is about 60% A
verage acceptance of a reviewer invitation is about 60% Junior reviewers provide better reviews than senior reviewersJunior reviewers provide better reviews than senior reviewers
Quality of the review is taken into account in editors decisionQuality of the review is taken into account in editors decision
A sk advice from an expert in the particular area and an expert in journal editing A sk advice from an expert in the particular area and an expert in journal editing
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 24/36
HOW ARE PAPERS JUDGED?HOW ARE PAPERS JUDGED?
SCIENTIFIC MERIT: Quality of the science, adequacy of the sample size, hypothesis adequatelySCIENTIFIC MERIT: Quality of the science, adequacy of the sample size, hypothesis adequatelystated and tested, and interpretation of the resultsstated and tested, and interpretation of the results
ORIGINA LITY: Is the paper addressing a question not studied, or inadequately studied in the past?ORIGINA LITY: Is the paper addressing a question not studied, or inadequately studied in the past?
IMPORT ANCE: Do the findings of the paper have significance in answering an important clinicalIMPORT ANCE: Do the findings of the paper have significance in answering an important clinicalquestion; either with immediate applicability, or in directing future research which will do so?question; either with immediate applicability, or in directing future research which will do so?
RE A DERSHIP INTEREST: Will this article be of interest to a majority of A JOG readers?RE A DERSHIP INTEREST: Will this article be of interest to a majority of A JOG readers?
QU A LITY OF THE M ANUSCRIPT: Is the A bstract sound & precise; Introduction brief & suitable;QU A LITY OF THE M ANUSCRIPT: Is the A bstract sound & precise; Introduction brief & suitable;Results clearly presented with appropriate tables/figures; Discussion through & sound, StatisticsResults clearly presented with appropriate tables/figures; Discussion through & sound, Statistics
& References appropriate, and is the overall paper well& References appropriate, and is the overall paper well--written & understandable?written & understandable?
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 25/36
Authors Should Also Authors Should Also
Be ReviewersBe Reviewers
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 26/36
Ethical Imperative to be a Reviewer Ethical Imperative to be a Reviewer
If you want your papers reviewed, then youIf you want your papers reviewed, then youshould be willing to return the favorshould be willing to return the favor
If you want fair, constructive, authoritativeIf you want fair, constructive, authoritative
reviews you should provide this kind of reviewreviews you should provide this kind of review ExposureExposure
You learn how to write a paper by doing reviews You learn how to write a paper by doing reviewsand seeing what others do right and wrongand seeing what others do right and wrong
You share the knowledge you have acquired You share the knowledge you have acquiredwith others writing paperswith others writing papers
Ultimately patient outcome is improved.Ultimately patient outcome is improved.
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 27/36
PearlsPearls Oversell your abstract, undersell your paperOversell your abstract, undersell your paper
Get advice from someone who has had abstracts and papers written and acceptedGet advice from someone who has had abstracts and papers written and accepted
Establish authorship when you design your studyEstablish authorship when you design your study both who and order of authorshipboth who and order of authorship
Have someone outside the group of authors read your abstract/paper before submissionHave someone outside the group of authors read your abstract/paper before submission
Dont forget to involve people in the department (early in the study) who are experts in the areaDont forget to involve people in the department (early in the study) who are experts in the area
Dont oversell results of secondary analysesDont oversell results of secondary analyses
Dont succumb to pressures real or perceived to include authors not really eligibleDont succumb to pressures real or perceived to include authors not really eligible
Write you abstract first, then the paper, then do the presentationWrite you abstract first, then the paper, then do the presentation
Read the Information for A uthors thoroughlyRead the Information for A uthors thoroughly
Do your literature search first when designing the study, intermittently during the study andDo your literature search first when designing the study, intermittently during the study and
again when writing the abstract/paperagain when writing the abstract/paper dont forget clinicaltrials.govdont forget clinicaltrials.gov
A lways have all authors read and approve abstract/paper before submitting and all revisions as A lways have all authors read and approve abstract/paper before submitting and all revisions as
wellwell
Brevity reigns!Brevity reigns!
Dont hesitate to call Journal staff or write editors with questionsDont hesitate to call Journal staff or write editors with questions
Prepublication consults are good things!Prepublication consults are good things!
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 28/36
Inappropriate ActsInappropriate Acts
FabricationFabrication
FalsificationFalsification
PlagiarismPlagiarism
Repetitive publicationRepetitive publication Violation of government rules of research Violation of government rules of research
Failure to retain original dataFailure to retain original data
Gift or honorary authorshipGift or honorary authorship Conflict of interest Conflict of interest
Order of authorshipOrder of authorship
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 29/36
Publishing Statistics
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 30/36
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 31/36
Manuscripts processed in 2007Manuscripts processed in 2007
Original Research ManuscriptsOriginal Research Manuscripts
Received in 2007 = 997Received in 2007 = 997
Decisions made in 2007Decisions made in 2007
A ccepted = 287 (29%) A ccepted = 287 (29%)
Declined = 718 (71%)Declined = 718 (71%)
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 32/36
Acceptance Rates Regular Acceptance Rates Regular
NonNon--Society ArticlesSociety Articles
43
37
32
29 29
0
5
10
15
20
25
30
35
40
45
2003 2004 2005 2006 2007
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 33/36
A ssign Reviewers/Reject without Review A ssign Reviewers/Reject without Review (5(5
days)days)
Reviews Completed to Editors DecisionReviews Completed to Editors Decision (37(37
days)days)
Revisions by A uthorsRevisions by A uthors (44 days)(44 days)
Decision on RevisionsDecision on Revisions (5 days)(5 days)
Total days from submission to INITI A L A cceptance = (92.6 days)Total days from submission to INITI A L A cceptance = (92.6 days)
Editorial Review TimeEditorial Review Time
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 34/36
Current Status (cont.)Current Status (cont.)
Publication ProcessPublication Process Summary Production (26 days)Summary Production (26 days)
Summary approval by author (18 days)Summary approval by author (18 days)
Summary approval by editor (5 days)Summary approval by editor (5 days)
Final A cceptance (released to production) toFinal A cceptance (released to production) toPublication (148 days / 4.9 months)Publication (148 days / 4.9 months)
Total days from submission to publicationTotal days from submission to publication
(316 days / 10 months)(316 days / 10 months)
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 35/36
Reviewers Time AllotedReviewers Time Alloted
Invitation to ReviewInvitation to Review
Time allowed to respondTime allowed to respond 7 days7 days
ReminderReminder 5 days5 days UninviteUninvite past 7 dayspast 7 days
Perform the reviewPerform the review
Time allowedTime allowed 14 days14 days
ReminderReminder 99--10 days10 days
Past duePast due at 14 daysat 14 days
8/8/2019 Writing Publishing Papers ACOG
http://slidepdf.com/reader/full/writing-publishing-papers-acog 36/36